港股異動 | 阜博集團(3738.HK)漲6.46% 與省廣集團附屬簽署戰略合作協議
格隆匯2月22日丨阜博集團(3738.HK)今日高開,現漲幅擴大至6.46%,報44.5港元,總市值205億港元。繼2020年與華數傳媒、螞蟻集團等建立合作之後,2021年阜博集團在中國的業務佈局又落一子,公司宣佈與省廣集團建立合作。省廣集團被稱為“中國廣吿營銷第一股”,也是正宗的“頭條概念股”,這也意味着阜博集團在中國短視頻領域也開始落子佈局,公司業務有望與抖音等短視頻平台建立關聯。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.